Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis

Related Keywords

,Rheumatology Research Foundation Investigator Award ,Spondyloarthritis Research ,Twitter ,Veterans Affairs Corporate Data Warehouse ,American College Of Rheumatology ,Treatment Network ,American College ,Newswise ,Heumatology American College Of Rheumatology Medical Conference Ankylosing Spondylitis As ,Cardiovascular Health ,Healthcare ,Heart Disease ,Medical Meetings ,Merican College Of Rheumatology Acr ,